Charles Schwab Investment Management Inc. Has $85.66 Million Stake in Henry Schein, Inc. (NASDAQ:HSIC)

Charles Schwab Investment Management Inc. increased its stake in shares of Henry Schein, Inc. (NASDAQ:HSICFree Report) by 0.5% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,175,061 shares of the company’s stock after buying an additional 6,184 shares during the quarter. Charles Schwab Investment Management Inc. owned about 0.94% of Henry Schein worth $85,662,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the stock. Cromwell Holdings LLC lifted its holdings in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares during the period. Simplify Asset Management Inc. lifted its stake in Henry Schein by 5.0% during the second quarter. Simplify Asset Management Inc. now owns 3,695 shares of the company’s stock worth $237,000 after purchasing an additional 175 shares during the last quarter. Sequoia Financial Advisors LLC lifted its stake in Henry Schein by 3.2% during the second quarter. Sequoia Financial Advisors LLC now owns 5,680 shares of the company’s stock worth $364,000 after purchasing an additional 176 shares during the last quarter. Studio Investment Management LLC boosted its holdings in shares of Henry Schein by 4.7% in the 2nd quarter. Studio Investment Management LLC now owns 4,502 shares of the company’s stock valued at $289,000 after purchasing an additional 204 shares in the last quarter. Finally, Mather Group LLC. increased its stake in shares of Henry Schein by 16.8% in the 2nd quarter. Mather Group LLC. now owns 1,502 shares of the company’s stock valued at $96,000 after purchasing an additional 216 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of the stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the sale, the chief operating officer now directly owns 87,706 shares in the company, valued at $6,577,950. This represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the transaction, the senior vice president now owns 71,833 shares in the company, valued at approximately $4,978,026.90. The trade was a 22.65 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.14% of the company’s stock.

Analyst Ratings Changes

Several analysts recently weighed in on HSIC shares. UBS Group reduced their price objective on Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research note on Wednesday, August 7th. Barrington Research restated an “outperform” rating and issued a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Robert W. Baird cut their target price on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research report on Wednesday, August 7th. Finally, Evercore ISI upped their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a report on Tuesday, October 8th. Six analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.38.

Read Our Latest Stock Report on HSIC

Henry Schein Stock Performance

Shares of Henry Schein stock opened at $77.66 on Thursday. The stock has a market cap of $9.68 billion, a price-to-earnings ratio of 31.96, a P/E/G ratio of 2.20 and a beta of 0.87. Henry Schein, Inc. has a twelve month low of $63.67 and a twelve month high of $82.63. The company’s fifty day moving average is $71.15 and its 200 day moving average is $69.78. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46.

Henry Schein (NASDAQ:HSICGet Free Report) last released its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.32 EPS. Sell-side analysts forecast that Henry Schein, Inc. will post 4.78 EPS for the current year.

About Henry Schein

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Further Reading

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.